Genotyping of Candida orthopsilosis clinical isolates by amplification fragment length polymorphism reveals genetic diversity among independent isolates and strain maintenance within patients.
Candida parapsilosis former groups II and III have recently been established as independent species named C. orthopsilosis and C. metapsilosis, respectively. In this report, 400 isolates (290 patients) previously classified as C. parapsilosis by conventional laboratory tests were screened by BanI digestion profile analysis of the secondary alcohol dehydrogenase gene fragment and by amplification fragment length polymorphism (AFLP). Thirty-three strains collected from 13 patients were identified as C. orthopsilosis, thus giving the first retrospective evidence that C. orthopsilosis was responsible for 4.5% of the infections/colonization attributed to C. parapsilosis. AFLP was proven to unambiguously identify C. orthopsilosis at the species level and efficiently delineate intraspecific genetic relatedness. A high percentage of polymorphic AFLP bands was observed for independent isolates collected from each patient. Statistical analysis of the pairwise genetic distances and bootstrapping revealed that clonal reproduction and recombination both contribute to C. orthopsilosis genetic population structure. AFLP patterns of sequential isolates obtained from two patients demonstrated that a successful strain colonization within the same patient occurred, as revealed by strain maintenance in various body sites. No association between AFLP markers and drug resistance was observed, and none of the clinical C. orthopsilosis isolates were found to produce biofilm in vitro.
Tavanti
Arianna
A
Dipartimento di Biologia, Università di Pisa, Pisa, Italy. atavanti@biologia.unipi.it
Hensgens
Lambert A M
LA
Ghelardi
Emilia
E
Campa
Mario
M
Senesi
Sonia
S
D000935:Antifungal Agents / Q000494:pharmacology; D018441:Biofilms; D002175:Candida / Q000235:genetics*; D002177:Candidiasis / Q000453:epidemiology* / Q000382:microbiology*; D025141:Drug Resistance, Fungal; D014644:Genetic Variation; D006801:Humans; D021141:Nucleic Acid Amplification Techniques / Q000379:methods*; D010802:Phylogeny; D013045:Species Specificity
D000935:Antifungal Agents